Keywords: agouron, reduces, net, loss, boosted, viracept, fiscal
Agouron Reduces Net Loss Boosted By Viracept
Article | 21 April 1997
In the fiscal third quarter ended March 31, 1997, AgouronPharmaceuticals reduced its net loss to just under $5 million, or 37 cents, from $11 million, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
